Additionally, the presence of CD44 on other cell types, including dopamine neurons [57] and microglia [52], suggests that GPNMB may represent a novel multi-target therapeutic approach to treat neurodegenerative diseases, including PD. Here, GPNMB is linked to neurodegenerative disease.